Combating ageing and physical decline, once deemed inevitable, has now been reduced to a treatable issue with a new drug developed by scientists.
Researchers state that their experimental drug extends the lifespan of middle-aged mice by up to 25% and could have a similar impact on humans.
Scientists from the Medical Research Council Laboratory of Molecular Biology (MRC LMS), Imperial College London, and Duke-NUS Medical School in Singapore injected 75-week-old mice with an anti-IL-11 antibody.